nipradilol has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esaki, T; Hayashi, T; Iguchi, A; Muto, E; Yamada, K | 1 |
| Hayashi, T; Iguchi, A; Kano, H; Matsui-Hirai, H; Sumi, D; Thakur, NK; Tsunekawa, T | 1 |
2 other study(ies) available for nipradilol and Arteriosclerosis
| Article | Year |
|---|---|
The beta adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit.
Topics: Adrenergic beta-Antagonists; Animals; Arteriosclerosis; Cattle; Cells, Cultured; Cholesterol; Cyclic GMP; Endothelium, Vascular; Immunohistochemistry; Male; Muscle Relaxation; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rabbits | 1997 |
Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Atenolol; Blood Pressure; Cholesterol; Cholesterol, Dietary; Endothelium, Vascular; Heart Rate; Isosorbide Dinitrate; Male; Muscle Relaxation; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Propanolamines; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasodilator Agents | 2002 |